Sorry, you need to enable JavaScript to visit this website.

Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors

A Phase 1 Dose Escalation and Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, and Anti-Tumor Activity of PF-07209960 in Participants With Advanced or Metastatic Solid Tumors

Category & Conditions: Cancer
Medicine: PF-07209960
ClinicalTrials.gov Identifier (NCT): NCT04628780
Protocol ID: C4011001
PrintDownload
Open Plain Language Summary Result: Click here